EXPRESSION OF p53 IN HUMAN BREAST CANCER


  • V. Fulga Nicolae Testemitanu” State University of Medicine and Pharmacy, Republic of Moldova

Abstract

EXPRESSION OF p53 IN HUMAN BREAST CANCER

References

1. Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 1998; 11:155-168.



2. Wolff A.C., Hammond M.E., Hicks D.G. et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J. Clin. Oncol. 2013; 31(31):3997-4013.



3. Suciu C, Muresan AM, Cornea R. et al. Semiautomated evaluation of Ki67 index in invasive ductal carcinoma of the breast. Oncol Lett. 2014; 7:107-114.



4. Azoulay S., Laé M., Fréneaux P., Merle S. et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod. Pathol. 2005; 18(12):1623-31.



5. Yamashita H., Nishio M., Toyama T. et al. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Breast Cancer Res. 2004; 6:R24-30.



6. Goldhirsch A., Winer E.P., Coates A.S., Gelber R.D. et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol. 2013;24(9):2206-23.



7. Silwal-Pandit L., Vollan H.K., Chin S.F., Rueda O.M., McKinney S., Osako T. et al. TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. Clin Cancer Res. 2014;20(13):3569-80.
Published
2017-12-29
How to Cite
Fulga, V. (2017). EXPRESSION OF p53 IN HUMAN BREAST CANCER. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 1(4), 52-55. https://doi.org/10.29256/v.01.04.2017.escbm18
Section
Selected abstracts